Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Craig Liden

Developmental - Behavioral Pediatrics Gibsonia, PA Medical Doctor

NPI 1902925589 CMS profile 958613

4156 Kenneth Dr, Gibsonia, PA 15044

Open in the dashboard

General payments

$9,779

187 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Craig Liden of Gibsonia, PA is reported in the CMS Open Payments database as having received $9,779 across 187 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Developmental - Behavioral Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $7,507 54
2022 General $898 59
2021 General $409 23
2020 General $323 19
2019 General $642 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig Liden
  • Developmental - Behavioral Pediatrics median
  • Middle half of Developmental - Behavioral Pediatrics
  • National median

In program year 2025, general payments to Craig Liden were reported at $0. Among 160 Developmental - Behavioral Pediatrics profiles paid that year, the median was $77 and the middle half received between $27 and $211.

Show as a table
Year Craig Liden Developmental - Behavioral Pediatrics median Middle half National median
2019 $642 $106 $28–$315 $163
2020 $323 $55 $19–$181 $114
2021 $409 $96 $25–$343 $132
2022 $898 $86 $23–$235 $149
2023 $7,507 $71 $25–$348 $160
2024 $0 $74 $25–$237 $164
2025 $0 $77 $27–$211 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Supernus Pharmaceuticals, Inc. $6,900 24 payments
  2. Ironshore Pharmaceuticals Inc. $855 51 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $576 34 payments
  4. Corium, Inc. $548 22 payments
  5. Neos Therapeutics, LP $421 27 payments
  6. Tris Pharma Inc $295 17 payments
  7. Arbor Pharmaceuticals, Inc. $80 5 payments
  8. Vertical Pharmaceuticals, LLC $62 4 payments
  9. Adlon Therapeutics L.P. $42 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,150 1 payment
  2. Food and Beverage $3,335 181 payments
  3. Travel and Lodging $1,289 4 payments
  4. Education $5 1 payment
Products named General payments · program years 2019–2023
  1. QELBREE $6,900 24 payments
  2. Azstarys $548 22 payments
  3. JORNAY PM Central Nervous Stimulant ADHD $488 35 payments
  4. COTEMPLA XR-ODT $305 20 payments
  5. VYVANSE $282 15 payments
  6. TRINTELLIX $236 15 payments
  7. Jornay PM 20mg capsules (Bottle of 100) $235 6 payments
  8. Adzenys XR-ODT Adhd $166 10 payments
  9. Adzenys XR-ODT Adhd $139 8 payments
  10. JORNAY PM Central Nervous System Stimulant $133 10 payments
  11. Other $553 34 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

187 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Developmental - Behavioral Pediatrics in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record